Addex Therapeutics, a clinical-stage pharmaceutical company, announced the completion of Part 1 of the phase 2 clinical study of ADX71149 (JNJ-40411813) for the treatment of epilepsy...
The Apollo Hospitals Group, one of Asia's largest and most trusted healthcare providers, has announced the launch of the Apollo Clinical Intelligence Engine, a clinical decision support tool that will be available to all India doctors through the...
Adherence specialists Aardex Group and remote research platform experts in the Clinpal team at Cambridge Cognition have teamed up to provide next-level adherence monitoring during hybrid and decentralized clinical trials (DCTs)...
Biotechnology poses some risks to human health and the environment. These risks must be carefully managed to ensure that the benefits of biotechnology outweigh the risks. Biotechnology poses some risks to human health and the environment
The Indian nutraceutical market is witnessing significant growth & hence nutraceutical companies will play a huge role in combating health issues.
Cipla, a Rs. 21,600 crore plus pharma major, reported single-digit revenue and profit growth in the third quarter ended December 2022. Its consolidated revenues increased by 6% to Rs. 5,810 crore, up from Rs. 5,479 crore in the same period last...
Sirnaomics Ltd., a leading biopharmaceutical firm in the research and development of RNAi therapies, reported that STP705 is moving forward in clinical trials for the treatment of two non-melanoma skin cancers:..
Ellipses Pharma (Ellipses), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model, announced that the US Food and Drug Administration (FDA) has...
The overall performance of the Telangana Drug Manufacturers Association (TDMA), which is the state affiliate of the Indian Drug Manufacturers’ Association (IDMA), will be improved to strengthen the activities connected with the pharma MSME sector...
Finance Minister Nirmala Sitharaman announced on Wednesday a new programme to promote pharmaceutical research and innovation through various centres of excellence. "We will also encourage industry to invest in R&D," ...
, CDSCO.jpg)
